In summary, our study provides evidence supporting a model in which CLGN, upregulated by endoplasmic reticulum stress (ERS), contributes to hepatocellular carcinoma (HCC) progression and drug resistance, potentially via the NF-κB pathway. Here, NFKB1 is linked to hepatocellular carcinoma.